Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.
暂无分享,去创建一个
[1] J. Cohn,et al. Neurohumoral control mechanisms in congestive heart failure. , 1981, American heart journal.
[2] T. Lohmeier,et al. Control of glomerular filtration rate by renin-angiotensin system. , 1977, The American journal of physiology.
[3] B. Greenberg,et al. Results of Long‐term Vasodilator Therapy in Patients with Refractory Congestive Heart Failure , 1981, Circulation.
[4] R. Gorlin,et al. Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure. , 1980, The New England journal of medicine.
[5] P. Cannon,et al. Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog. , 1981, The Journal of clinical investigation.
[6] J. Hollifield. Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. , 1984, The American journal of medicine.
[7] B. W. East,et al. Captopril in heart failure. A double blind controlled trial. , 1984, British heart journal.
[8] G. L. Neifeld. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure , 1985 .
[9] M. Packer,et al. Sudden unexpected death in patients with congestive heart failure: a second frontier. , 1985, Circulation.
[10] F. Smith,et al. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. , 1976, The Journal of clinical investigation.
[11] N. Fineberg,et al. Abnormalities of sodium and H2O handling in chronic obstructive lung disease. , 1982, Archives of internal medicine.
[12] J. Cohn,et al. The neurohumoral axis in congestive heart failure. , 1984, Annals of internal medicine.
[13] W. Grossman,et al. Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy? , 1985, Circulation.
[14] V. Arroyo,et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. , 1981, Annals of internal medicine.
[15] B. Massie,et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. , 1985, The American journal of cardiology.
[16] J. W. Aiken,et al. Angiotensin II Stimulation of Renal Prostaglandin Synthesis Elevates Circulating Prostacyclin in the Dog , 1980, Journal of cardiovascular pharmacology.
[17] J. Cohn,et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.
[18] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[19] S. Massry,et al. NEUROLOGICAL MANIFESTATIONS AND MORBIDITY OF HYPONATREMIA: CORRELATION WITH BRAIN WATER AND ELECTROLYTES , 1976, Medicine.
[20] H. Burchell,et al. Focal myocarditis associated with pheochromocytoma. , 1966, The New England journal of medicine.
[21] S. Yusuf,et al. Potential for altering the natural history of congestive heart failure: need for large clinical trials. , 1985, The American journal of cardiology.
[22] G. Riegger,et al. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade. , 1984, The American journal of cardiology.
[23] J. Brown,et al. Renin relationships in congestive cardiac failure, treated and untreated. , 1970, American heart journal.
[24] M. Packer,et al. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure. , 1984, Journal of the American College of Cardiology.
[25] C. Furberg,et al. Effect of vasodilators on survival in chronic congestive heart failure. , 1985, The American journal of cardiology.
[26] M. Packer. Is the renin-angiotensin system really unnecessary in patients with severe chronic heart failure: The price we pay for interfering with evolution* , 1985 .
[27] M. Pfeffer,et al. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. , 1985, Circulation.
[28] P. Martorana. The role of cyclic AMP in isoprenaline‐induced cardiac necroses in the rat * , 1971, The Journal of pharmacy and pharmacology.
[29] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[30] Shebuski Rj,et al. Angiotensin II stimulation of renal prostaglandin synthesis elevates circulating prostacyclin in the dog. , 1980 .
[31] J. Cohn,et al. Increased plasma arginine vasopressin levels in patients with congestive heart failure. , 1983, Journal of the American College of Cardiology.
[32] R. Anderson,et al. Mechanism of effect of thoracic inferior vena cava constriction on renal water excretion. , 1974, The Journal of clinical investigation.
[33] J. Halperin,et al. Determinants of clinical response and survival in patients with congestive heart failure treated with captopril. , 1982, American heart journal.
[34] K. Swedberg,et al. PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.
[35] M. Packer,et al. Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition. , 1984, Annals of internal medicine.
[36] T. Berl,et al. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. , 1981, The New England journal of medicine.
[37] M. Moeschberger,et al. Factors influencing the one-year mortality of dilated cardiomyopathy. , 1984, The American journal of cardiology.
[38] N. Breslow. Covariance analysis of censored survival data. , 1974, Biometrics.
[39] M. Pfeffer,et al. Influence of Chronic Captopril Therapy on the Infarcted Left Ventricle of the Rat , 1985, Circulation research.
[40] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[41] M. Brown,et al. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. , 1985, The New England journal of medicine.
[42] G. Riegger,et al. Antidiuretic hormone in congestive heart failure. , 1982, The American journal of medicine.
[43] J. Cohn,et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. , 1985, Annals of internal medicine.
[44] M. Packer,et al. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. , 1985, Circulation.
[45] M. Packer,et al. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders. , 1984, The American journal of cardiology.
[46] R. Gorlin,et al. Determinants of Drug Response in Severe Chronic Heart Failure. 1. Activation of Vasoconstrictor Forces During Vasodilator Therapy , 1981, Circulation.
[47] J. Cohn,et al. Hyponatraemia as a marker for high renin heart failure. , 1982, British heart journal.
[48] D. Ganten,et al. Plasma angiotensin II concentrations and experimentally induced thirst. , 1981, The American journal of physiology.
[49] M. Packer,et al. Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. , 1984, The New England journal of medicine.
[50] J. Bonjour,et al. Stimulation of ADH release by the renin-angiotensin system. , 1970, The American journal of physiology.
[51] L. Horowitz,et al. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. , 1983, Journal of the American College of Cardiology.
[52] E. Espiner,et al. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. , 1980, Clinical science.
[53] D.,et al. Regression Models and Life-Tables , 2022 .
[54] B. Massie,et al. Long‐term Vasodilator Therapy for Heart Failure: Clinical Response and its Relationship to Hemodynamic Measurements , 1981, Circulation.
[55] M. Brown,et al. Hypokalemia from beta 2-receptor stimulation by circulating epinephrine. , 1983, The American journal of cardiology.
[56] J. Fitzsimons,et al. The effect on drinking in the rat of intravenous infusion of angiotensin, given alone or in combination with other stimuli of thirst , 1969, The Journal of physiology.
[57] N. Hollenberg,et al. Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. , 1984, Annals of internal medicine.
[58] N. Hollenberg,et al. Relation of the Renin‐Angiotensin-Aldosterone System to Clinical State in Congestive Heart Failure , 1981, Circulation.